Piper Jaffray Defends Alder Despite Stock Slump, Looks To What's Next In Migraine Management
June 27, 2017 at 12:11 PM EDT
Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR) lost more than 20 percent on Tuesday and hit a new 52-week low of $13.80 despite ...
